NCT05070468

Brief Summary

Pregnant women with a gestational age of 38 weeks and older admitted to Labor Of Kamali Hospital, for termination of pregnancy, by accident and based on the a statistician did coding to identify groups of users of pill A or pill B, 14 pills are used vaginally. The patients and the researcher is blinded and the pharmacist delivers the dexamethasone and placebo tablets with codes A and B to the researcher.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2020

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 23, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 7, 2021

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

December 12, 2024

Completed
Last Updated

December 12, 2024

Status Verified

October 1, 2024

Enrollment Period

2 months

First QC Date

September 23, 2021

Results QC Date

July 3, 2022

Last Update Submit

October 26, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • First Bishop Score

    The total Bishop score is calculated by assessing the following five components of manual vaginal examination by a trained professional: Cervical dilation, Cervical effacement, Cervical consistency, Cervical position, and Fetal station. Dilation (score): closed(0), 1-2 cm (1), 3-4cm (2), 5\>= (3) Effacement (score): 0-30% (0), 40-50% (1), 60-70% (2), 80%\>= (3) Consistency (score): Firm (0), moderately firm (1), soft (2) Position (score): posterior (0), mid posterior (1), anterior(2) Station (score): -3 (0), -2 (1), -1 and 0 (2), +1 and +2 (3) The total Bishop's score which sums up all subscores can range from zero to 13, with zero meaning that the patient is not ready for induction and 13 indicating a better chance for successful induction for delivery (outcome).

    at the beginning of the study

  • Second Bishop Score

    The total Bishop score is calculated by assessing the following five components of manual vaginal examination by a trained professional: Cervical dilation, Cervical effacement, Cervical consistency, Cervical position, and Fetal station. Dilation (score): closed(0), 1-2 cm (1), 3-4cm (2), 5\>= (3) Effacement (score): 0-30% (0), 40-50% (1), 60-70% (2), 80%\>= (3) Consistency (score): Firm (0), moderately firm (1), soft (2) Position (score): posterior (0), mid posterior (1), anterior(2) Station (score): -3 (0), -2 (1), -1 and 0 (2), +1 and +2 (3) The total Bishop's score which sums up all subscores can range from zero to 13, with zero meaning that the patient is not ready for induction and 13 indicating a better chance for successful induction for delivery (outcome).

    6 hours after vaginally tablets installment

  • The Latent Phase of Labor

    measured by Vaginal Examination

    from the beginning of the study to the time of 6 cm dilation of cervix

Study Arms (2)

Group A

ACTIVE COMPARATOR

Prescribing Vaginally Dexamethasone tablets to the Group A

Drug: Dexamethasone 0.5mg

Group B

PLACEBO COMPARATOR

Prescribing Vaginally placebo tablets to the Group B

Drug: Placebo

Interventions

Pregnant women with a gestational age of 38 weeks and older admitted to Labor Of Kamali Hospital, for termination of pregnancy, by accident and based on the coding done by a statistician to identify groups of users of pill A or pill B, 14 pills are used vaginally . The client and the researcher are blinded and the pharmacist delivers the dexamethasone and placebo tablets with codes A and B to the researcher.

Also known as: Pill A
Group A

Pregnant women with a gestational age of 38 weeks and older admitted to Labor Of Kamali Hospital, for termination of pregnancy, by accident and based on the coding done by a statistician to identify groups of users of pill A or pill B, 14 pills are used vaginally . The client and the researcher are blinded and the pharmacist delivers the dexamethasone and placebo tablets with codes A and B to the researcher.

Also known as: Pill B
Group B

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Iranian Women
  • Primigravid pregnancy
  • Normal of Body Mass Index
  • Single Pregnancy
  • presentation cephalic in sonography
  • Gestational age 38 weeks
  • Bishop score 2 and less
  • Normal Non Stress
  • Test Estimate of Fetus Weight 2500-4000 gr
  • Didn't take hormonal, herbal and chemical drugs
  • having a healthy water bag

You may not qualify if:

  • Have Medicine And Midwifery Complication
  • Lack of Desire for Cooperation
  • Fetal Immobility
  • Maternal Bleeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alborz university of medical sciences

Karaj, 3149779453, Iran

Location

Related Publications (1)

  • Farahani M, Nirouei M, Moghadam S, Hashemnejad M, Mashak B, Alinia T, Torabi S. The Effect of Using Dexamethasone Tablets Vaginally for Improving Cervical Bishop Score in Nulliparous Pregnant Women: A Randomized Clinical Trial. Curr Ther Res Clin Exp. 2023 Apr 6;98:100702. doi: 10.1016/j.curtheres.2023.100702. eCollection 2023.

MeSH Terms

Interventions

Dexamethasone

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Results Point of Contact

Title
Dr. Masoumeh Farahani
Organization
Alborz University of Medical Sciences

Study Officials

  • Masoumeh Farahani, Doctor

    Assistant Professor of Alborz University of Medical Sciences

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Pregnant women with a gestational age of 38 weeks and older admitted to Labor Of Kamali Hospital, for termination of pregnancy, by accident and based on the coding done by a statistician to identify groups of users of pill A or pill B, 14 pills are used vaginally . The client and the researcher are blinded and the pharmacist delivers the dexamethasone and placebo tablets with codes A and B to the researcher.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects are assigned to two groups by randomization block balanced method allocation and using quadruple blocks. In this case, there are 6 modes And in each case, 2 people will be in the control group and 2 people will be in the intervention group. Thus, by using the table of random numbers and assigning the numbers 1 to 6 to groups of 4 people, people are finally assigned to two groups of intervention and control.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 23, 2021

First Posted

October 7, 2021

Study Start

November 22, 2020

Primary Completion

January 21, 2021

Study Completion

March 21, 2021

Last Updated

December 12, 2024

Results First Posted

December 12, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations